• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓间充质干细胞经系统给药后随时间向梗死心脏的迁移。

Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart.

机构信息

Department of Morphology, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Cell Transplant. 2010;19(2):219-30. doi: 10.3727/096368909X479677. Epub 2009 Nov 10.

DOI:10.3727/096368909X479677
PMID:19906330
Abstract

In this study the time course of homing and the body distribution of systemically delivered bone marrow mesenchymal stem cells (BM-MSCs) after myocardial infarction (MI) were evaluated. BM-MSCs were isolated from Wistar rats, expanded in vitro, and their phenotypical characterization was performed by flow cytometer. Rats were randomly divided into three groups: control, sham MI, and MI. BM-MSCs (5 x 10(6)) were labeled with (99m)Tc-HMPAO and injected through the tail vein 7 days after MI. Gamma camera imaging was performed at 5, 15, 30, and 60 min after cell inoculation. Due to the (99m)Tc short half-life, cell migration and location were also evaluated in heart sections using DAPI-labeled cells 7 days after transplantation. Phenotypical characterization showed that BM-MSCs were CD90(+), CD73(+), CD54(+), and CD45(-). Five minutes after (99m)Tc-HMPAO-labeled cell injection, they were detected in various tissues. The cells migrated mainly to the lungs (approximately 70%) and, in small amounts, to the heart, kidneys, spleen, and bladder. The number of cells in the heart and lungs decreased after 60 min. MI markedly increased the amount of cells in the heart, but not in the lungs, during the period of observation (4.55 +/- 0.32 vs. 6.34 +/- 0.67% of uptake in infarcted hearts). No significant differences were observed between control and sham groups. Additionally, 7 days after DAPI-labeled cells injection, they were still detected in the heart but only in infarcted areas. These results suggest that the migration of systemically delivered BM-MSCs to the heart is time dependent and MI specifically increases BM-MSCs homing to injured hearts. However, the systemic delivery is limited by cell entrapment in the lungs.

摘要

在这项研究中,评估了骨髓间充质干细胞(BM-MSCs)在心肌梗死(MI)后归巢的时间过程和体内分布。BM-MSCs 从 Wistar 大鼠中分离出来,在体外扩增,并通过流式细胞仪进行表型特征分析。大鼠随机分为三组:对照组、假 MI 组和 MI 组。在 MI 后 7 天,将 5 x 10(6)个 BM-MSCs 用(99m)Tc-HMPAO 标记,并通过尾静脉注射。在细胞接种后 5、15、30 和 60 分钟进行伽马相机成像。由于(99m)Tc 半衰期短,还使用 DAPI 标记的细胞在移植后 7 天评估心脏切片中的细胞迁移和位置。表型特征表明 BM-MSCs 为 CD90(+)、CD73(+)、CD54(+)和 CD45(-)。在(99m)Tc-HMPAO 标记细胞注射后 5 分钟,它们在各种组织中被检测到。细胞主要迁移到肺部(约 70%),少量迁移到心脏、肾脏、脾脏和膀胱。60 分钟后,心脏和肺部的细胞数量减少。MI 在观察期间(梗死心脏中摄取的 4.55 +/- 0.32%与 6.34 +/- 0.67%)明显增加了心脏中的细胞数量,但肺部没有增加。对照组和假 MI 组之间无显著差异。此外,在 DAPI 标记细胞注射后 7 天,仍在心脏中检测到,但仅在梗死区。这些结果表明,系统给予的 BM-MSCs 向心脏的迁移是时间依赖性的,MI 特异性增加了 BM-MSCs 向受损心脏的归巢。然而,全身给药受到细胞在肺部被捕获的限制。

相似文献

1
Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart.骨髓间充质干细胞经系统给药后随时间向梗死心脏的迁移。
Cell Transplant. 2010;19(2):219-30. doi: 10.3727/096368909X479677. Epub 2009 Nov 10.
2
Impact of escaped bone marrow mesenchymal stromal cells on extracardiac organs after intramyocardial implantation in a rat myocardial infarction model.心肌内注射骨髓间充质基质细胞对大鼠心肌梗死模型心外器官的影响。
Cell Transplant. 2010;19(12):1599-607. doi: 10.3727/096368910X513982. Epub 2010 Aug 17.
3
Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.间充质干细胞参与血管生成并改善心肌缺血再灌注大鼠模型的心脏功能。
Eur J Cardiothorac Surg. 2006 Aug;30(2):353-61. doi: 10.1016/j.ejcts.2006.02.070. Epub 2006 Jul 10.
4
Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.骨髓间充质干细胞联合肝细胞生长因子经非梗死相关动脉移植治疗急性心肌梗死的实验研究
Gene Ther. 2006 Nov;13(22):1564-8. doi: 10.1038/sj.gt.3302820. Epub 2006 Jun 29.
5
Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction.实验性心肌梗死大鼠中心肌基质细胞衍生因子1表达的时间进程及静脉注射骨髓干细胞的有益作用
Basic Res Cardiol. 2005 May;100(3):217-23. doi: 10.1007/s00395-005-0521-z. Epub 2005 Mar 10.
6
Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.过表达肝细胞生长因子的骨髓间充质干细胞对预防梗死大鼠左心室重构和心功能改善的作用。
Cell Biochem Funct. 2012 Oct;30(7):574-81. doi: 10.1002/cbf.2836. Epub 2012 May 16.
7
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.将骨髓间充质干细胞全身性输送至梗死心肌:可行性、细胞迁移及体内分布
Circulation. 2003 Aug 19;108(7):863-8. doi: 10.1161/01.CIR.0000084828.50310.6A. Epub 2003 Aug 4.
8
Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits.使用接种间充质干细胞的小肠黏膜下层修复兔梗死心肌
Biomaterials. 2009 Jul;30(19):3234-40. doi: 10.1016/j.biomaterials.2009.02.013. Epub 2009 Mar 3.
9
Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.人骨髓间充质干细胞移植可改善大鼠受损的心脏功能。
Int J Cardiol. 2007 Feb 7;115(2):220-8. doi: 10.1016/j.ijcard.2006.03.028. Epub 2006 Aug 4.
10
Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats.间充质干细胞既不完全获得成熟心肌细胞的电生理特性,也不会在梗死大鼠中引发室性心律失常。
Basic Res Cardiol. 2012 Jul;107(4):274. doi: 10.1007/s00395-012-0274-4. Epub 2012 Jun 29.

引用本文的文献

1
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.在轻度阿尔茨海默病中使用laromestrocel进行异基因间充质干细胞治疗:一项随机对照2a期试验。
Nat Med. 2025 Apr;31(4):1257-1266. doi: 10.1038/s41591-025-03559-0. Epub 2025 Mar 10.
2
MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research.基于间充质干细胞的神经疾病细胞治疗:临床前和临床研究文献的简明综述。
Biomolecules. 2024 Apr 30;14(5):538. doi: 10.3390/biom14050538.
3
Delivery of Mesenchymal Stem Cells during Hypothermic Machine Perfusion in a Translational Kidney Perfusion Study.
在转化肾脏灌注研究中的低温机器灌注期间输送间充质干细胞。
Int J Mol Sci. 2024 May 5;25(9):5038. doi: 10.3390/ijms25095038.
4
Cold Atmospheric Pressure Plasma-Activated Medium Modulates Cellular Functions of Human Mesenchymal Stem/Stromal Cells In Vitro.冷等离体压等离子体激活介质调节人骨髓间充质干细胞/基质细胞的体外细胞功能。
Int J Mol Sci. 2024 May 1;25(9):4944. doi: 10.3390/ijms25094944.
5
Advancing Tissue Damage Repair in Geriatric Diseases: Prospects of Combining Stem Cell-Derived Exosomes with Hydrogels.推进老年疾病组织损伤修复:干细胞衍生外泌体与水凝胶联合应用的前景。
Int J Nanomedicine. 2024 Apr 29;19:3773-3804. doi: 10.2147/IJN.S456268. eCollection 2024.
6
Research Progress on Cardiac Tissue Construction of Mesenchymal Stem Cells for Myocardial Infarction.间充质干细胞用于心肌梗死心脏组织构建的研究进展
Curr Stem Cell Res Ther. 2024;19(7):942-958. doi: 10.2174/1574888X18666230823091017.
7
Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.间充质干细胞在 COVID-19 治疗中的潜在治疗应用机制。
Cell Transplant. 2023 Jan-Dec;32:9636897231184611. doi: 10.1177/09636897231184611.
8
Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges.基于间充质基质细胞的胰腺癌靶向治疗:进展与挑战
Int J Mol Sci. 2023 Feb 10;24(4):3559. doi: 10.3390/ijms24043559.
9
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.SARS-CoV-2 诱导的细胞因子风暴在多器官衰竭中的作用:分子途径和潜在的治疗选择。
Int Immunopharmacol. 2022 Dec;113(Pt B):109428. doi: 10.1016/j.intimp.2022.109428. Epub 2022 Nov 7.
10
Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathway.硫酸葡聚糖通过激活 Wnt 信号通路抑制细胞间黏附分子 1(ICAM1)的表达并下调 E-钙黏蛋白,从而防止人多能干细胞在 3D 培养中过度聚集。
Stem Cell Res Ther. 2022 May 26;13(1):218. doi: 10.1186/s13287-022-02890-4.